Skip to main content
. Author manuscript; available in PMC: 2016 Jun 29.
Published in final edited form as: J Patient Cent Res Rev. 2016 Apr 22;3(2):111–115. doi: 10.17294/2330-0698.1214

Table 1.

PCV13 Efficacy in First Episode Vaccine-Type Pneumococcal Disease

PCV13
(N=42,240)		 Placebo
(N=42,256)		 % Vaccine
Efficacy		 P Value
1st episode Vaccine-type CAP* 49 90 45.6% <0.001
1st episode Vaccine-type Nonbacteremic, Noninvasive CAP 33 60 45.0% 0.007
1st episode Vaccine-type Invasive Pneumococcal Disease 7 28 75.0% <0.001

Adapted from Bonten et al.5

*

Community-acquired pneumonia